Technical Analysis for CPIX - Cumberland Pharmaceuticals Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 1.51 | 0.67% | 0.01 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| NR7-2 | Range Contraction | 0.00% | |
| Stochastic Reached Oversold | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.67% | |
| NR7 | Range Contraction | 0.67% | |
| Inside Day | Range Contraction | 0.67% | |
| Lower Bollinger Band Touch | Weakness | 0.67% | |
| 20 DMA Resistance | Bearish | -3.82% | |
| Gapped Up | Strength | -3.82% |
| Alert | Time |
|---|---|
| Up 2% | 1 day ago |
| Up 1% | 1 day ago |
| Down 2 % | 2 days ago |
| Down 1% | 2 days ago |
| 10 DMA Resistance | 3 days ago |
Get a Trading Sidekick!
- Earnings date: 05/07/2024
Cumberland Pharmaceuticals Inc. Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Drugs Pain Clinical Development Medication Gastroenterology Analgesics Constipation Fever Hepatotoxins Paracetamol Prescription Product Prescription Products Hepatorenal Syndrome Treatment Of Hepatorenal Syndrome
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.3587 |
| 52 Week Low | 1.42 |
| Average Volume | 9,758 |
| 200-Day Moving Average | 1.83 |
| 50-Day Moving Average | 1.69 |
| 20-Day Moving Average | 1.59 |
| 10-Day Moving Average | 1.57 |
| Average True Range | 0.15 |
| RSI (14) | 43.50 |
| ADX | 14.41 |
| +DI | 13.04 |
| -DI | 16.68 |
| Chandelier Exit (Long, 3 ATRs) | 1.40 |
| Chandelier Exit (Short, 3 ATRs) | 1.87 |
| Upper Bollinger Bands | 1.77 |
| Lower Bollinger Band | 1.42 |
| Percent B (%b) | 0.26 |
| BandWidth | 21.69 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.04 |
| MACD Histogram | -0.0025 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.63 | ||||
| Resistance 3 (R3) | 1.64 | 1.61 | 1.61 | ||
| Resistance 2 (R2) | 1.61 | 1.58 | 1.61 | 1.60 | |
| Resistance 1 (R1) | 1.56 | 1.56 | 1.59 | 1.55 | 1.60 |
| Pivot Point | 1.53 | 1.53 | 1.54 | 1.53 | 1.53 |
| Support 1 (S1) | 1.48 | 1.50 | 1.51 | 1.47 | 1.42 |
| Support 2 (S2) | 1.45 | 1.48 | 1.45 | 1.42 | |
| Support 3 (S3) | 1.40 | 1.45 | 1.41 | ||
| Support 4 (S4) | 1.39 |
